chr17-45289226-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_003954.5(MAP3K14):c.326+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00157 in 1,613,466 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 11 hom. )
Consequence
MAP3K14
NM_003954.5 intron
NM_003954.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.695
Genes affected
MAP3K14 (HGNC:6853): (mitogen-activated protein kinase kinase kinase 14) This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 17-45289226-C-T is Benign according to our data. Variant chr17-45289226-C-T is described in ClinVar as [Benign]. Clinvar id is 544330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-45289226-C-T is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 11 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K14 | NM_003954.5 | c.326+10G>A | intron_variant | Intron 3 of 15 | ENST00000344686.8 | NP_003945.2 | ||
MAP3K14 | XM_047436997.1 | c.326+10G>A | intron_variant | Intron 3 of 14 | XP_047292953.1 | |||
MAP3K14 | XM_047436998.1 | c.326+10G>A | intron_variant | Intron 4 of 15 | XP_047292954.1 | |||
MAP3K14 | XM_011525441.3 | c.326+10G>A | intron_variant | Intron 4 of 16 | XP_011523743.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K14 | ENST00000344686.8 | c.326+10G>A | intron_variant | Intron 3 of 15 | 1 | NM_003954.5 | ENSP00000478552.1 | |||
MAP3K14 | ENST00000376926.8 | c.326+10G>A | intron_variant | Intron 2 of 14 | 1 | ENSP00000482657.1 | ||||
MAP3K14 | ENST00000617331.3 | c.326+10G>A | intron_variant | Intron 4 of 16 | 5 | ENSP00000480974.3 |
Frequencies
GnomAD3 genomes AF: 0.00113 AC: 172AN: 152082Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
172
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00206 AC: 512AN: 249142Hom.: 2 AF XY: 0.00257 AC XY: 347AN XY: 135160
GnomAD3 exomes
AF:
AC:
512
AN:
249142
Hom.:
AF XY:
AC XY:
347
AN XY:
135160
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00162 AC: 2361AN: 1461266Hom.: 11 Cov.: 30 AF XY: 0.00187 AC XY: 1357AN XY: 726954
GnomAD4 exome
AF:
AC:
2361
AN:
1461266
Hom.:
Cov.:
30
AF XY:
AC XY:
1357
AN XY:
726954
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00116 AC: 176AN: 152200Hom.: 1 Cov.: 32 AF XY: 0.00126 AC XY: 94AN XY: 74406
GnomAD4 genome
AF:
AC:
176
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
94
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
NIK deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at